Drug intelligence / Profile preview

Galli Ad

Development stage: Unknown
Lead developer: IRE ELiT
Modality: Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration: Intravenous

Overview

Galli Ad (also known as GalliAd) is a pharmaceutical-grade 68Germanium/68Gallium (68Ge/68Ga) radionuclide generator developed and manufactured by IRE ELiT. It functions as a closed, integrated system that produces Gallium-68 chloride solution through the radioactive decay of its parent isotope, Germanium-68. The resulting Gallium-68 is used for the in vitro radiolabeling of various vector molecules (such as PSMA or DOTATATE) to create radiopharmaceuticals for positron emission tomography (PET) diagnostic imaging. It is primarily utilized in oncology for the detection and staging of neuroendocrine tumors and prostate cancer. In the United States and Canada, the same generator technology is marketed under the brand name Galli Eo.

Brand names: Galli AdGalliAdGalli Eo
Other names: 68Germanium/68Gallium radionuclide generator68Ge/68Ga generatorGermanium-68/Gallium-68 generator

Beyond the preview

Go deeper on Galli Ad.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galli Ad.

Explore the full profile